methicillin
简明释义
n. 甲氧西林(等于 methicil-lin sodium)
英英释义
单词用法
对甲氧西林敏感的 | |
耐甲氧西林的 | |
用甲氧西林治疗 | |
对甲氧西林敏感 |
同义词
反义词
青霉素 | 青霉素常用于治疗细菌感染。 | ||
氨苄西林 | Ampicillin is effective against a variety of gram-positive and some gram-negative bacteria. | 氨苄西林对多种革兰阳性菌和一些革兰阴性菌有效。 |
例句
1.Staphylococcus aureus (hospital isolates) : percentage of methicillin-resistant strains, 2007, Latin America and the Caribbean.
金黄色葡萄球菌(医院株):2007年拉丁美洲和加勒比地区耐甲氧西林的百分比-英文。
2.A growing number of bacteria are becoming resistant to antibiotics. This is especially true for MRSA (methicillin-resistant Staphylococcus aureus).
越来越多的细菌开始出现耐药现象,对于MRSA尤其如此。
3.Vancomycin, a glycopeptide antibiotic, was used as the first-line drug in treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
万古霉素是目前临床上用于治疗由甲氧西林耐药金葡菌(MRSA)引起的严重感染疾病的首选药物。
4.To study the present situation of nosocomial infection and drug resistance of Methicillin-resistant Staphylococcus Aureus (MRSA), provide reference for clinical rational use of drugs.
目的监测耐甲氧西林金黄色葡萄球菌(MRSA)医院感染现状及耐药性,为临床合理选用抗菌药物提供参考。
5.He said the emergence of "superbugs" such as methicillin-resistant staphylococcus aureus (MRSA) is causing the growing problem of hospital-acquired infections.
他还说道,像耐药性葡萄球菌(MRSA)这种“超级病菌”的出现,是医院感染问题增加的原因。
6.Objective To analyze the clinical characteristics of pneumonia caused by methicillin-resistant staphylococcus aureus (MRSA) and to investigate the drug sensitivity of MRSA stains.
目的分析和总结耐甲氧西林金黄色葡萄球菌(MRSA)肺炎发病的高危因素、临床特点及药物敏感性的分布情况。
7.Objective To develop a rapid and effective method for the diagnosis of methicillin resistant staphylococcal infection.
目的建立一种能快速有效地对葡萄球菌感染进行病原体诊断的方法。
8.After several tests, the bacteria were found to be methicillin-resistant.
经过几次测试,发现细菌对美克西林耐药。
9.In cases of severe infection, methicillin may be administered intravenously.
在严重感染的情况下,可能会通过静脉注射给药美克西林。
10.The development of methicillin-resistant Staphylococcus aureus (MRSA) is a major concern in hospitals.
耐美克西林金黄色葡萄球菌(MRSA)的出现是医院中的一个主要问题。
11.Doctors often prescribe methicillin for treating staphylococcal infections.
医生通常会开处方美克西林来治疗葡萄球菌感染。
12.The patient was diagnosed with an infection resistant to methicillin.
患者被诊断出感染对美克西林耐药。
作文
Methicillin is a type of antibiotic that was developed to combat infections caused by staphylococci, particularly those strains that are resistant to penicillin. The introduction of methicillin (美克西林) in the 1960s marked a significant advancement in the field of medicine, as it provided an effective treatment option for patients suffering from serious bacterial infections. However, the emergence of methicillin-resistant Staphylococcus aureus (MRSA) has posed new challenges for healthcare professionals and researchers alike.The story of methicillin (美克西林) begins with the discovery of penicillin by Alexander Fleming in 1928. While penicillin was revolutionary in treating bacterial infections, some bacteria quickly adapted, developing resistance to this antibiotic. In response to this growing problem, scientists sought to create new antibiotics that could effectively target these resistant strains. Methicillin (美克西林) was one such solution, designed specifically to resist the beta-lactamase enzymes produced by certain bacteria that rendered penicillin ineffective.Initially, methicillin (美克西林) was hailed as a miracle drug. It was widely used in hospitals and clinics, and many patients experienced rapid recovery from infections that were once deemed life-threatening. The success of methicillin (美克西林) led to its widespread use, and it became a standard treatment for staphylococcal infections.However, as the use of methicillin (美克西林) became more prevalent, so did the emergence of resistant bacteria. MRSA was first identified in the 1970s, and it quickly became a major public health concern. This strain of staphylococcus aureus is resistant to the effects of methicillin (美克西林) and other antibiotics in the same class, making it difficult to treat. The rise of MRSA infections has led to increased morbidity and mortality rates, particularly in hospital settings where vulnerable patients are at higher risk.The emergence of MRSA has prompted extensive research into alternative treatments and preventive measures. Healthcare facilities have implemented strict infection control protocols, including hand hygiene practices and the use of personal protective equipment, to minimize the spread of these resistant bacteria. Additionally, researchers are exploring new antibiotics and treatment strategies that can effectively target MRSA and other resistant strains.In conclusion, methicillin (美克西林) played a crucial role in the fight against bacterial infections, but its effectiveness has been challenged by the rise of antibiotic resistance. The ongoing battle against MRSA serves as a reminder of the importance of responsible antibiotic use and the need for continued research in the field of infectious diseases. As we move forward, it is essential to learn from the past and develop innovative solutions to combat the ever-evolving landscape of bacterial resistance.
美克西林是一种抗生素,旨在对抗由葡萄球菌引起的感染,特别是那些对青霉素耐药的菌株。美克西林(methicillin)在1960年代的推出标志着医学领域的一项重大进展,因为它为患有严重细菌感染的患者提供了有效的治疗选择。然而,耐甲氧西林金黄色葡萄球菌(MRSA)的出现给医疗专业人员和研究人员带来了新的挑战。美克西林(methicillin)的故事始于亚历山大·弗莱明在1928年发现青霉素。尽管青霉素在治疗细菌感染方面具有革命性意义,但一些细菌迅速适应,发展出对这种抗生素的耐药性。为了应对这一日益严重的问题,科学家们寻求创造新的抗生素,以有效针对这些耐药菌株。美克西林(methicillin)就是这样一种解决方案,专门设计用来抵抗某些细菌产生的β-内酰胺酶,这使得青霉素失效。最初,美克西林(methicillin)被誉为神奇药物。它在医院和诊所广泛使用,许多患者从以往被认为危及生命的感染中迅速康复。美克西林(methicillin)的成功导致其广泛使用,并成为治疗葡萄球菌感染的标准疗法。然而,随着美克西林(methicillin)的使用变得更加普遍,耐药细菌的出现也随之增加。MRSA在1970年代首次被识别,并迅速成为一个主要的公共健康问题。这种金黄色葡萄球菌耐受美克西林(methicillin)及同类其他抗生素的影响,使其治疗变得困难。MRSA感染的增加导致发病率和死亡率上升,尤其是在医院环境中,脆弱的患者面临更高的风险。MRSA的出现促使对替代治疗和预防措施进行广泛研究。医疗机构实施了严格的感染控制协议,包括手部卫生实践和使用个人防护装备,以减少这些耐药细菌的传播。此外,研究人员正在探索可以有效针对MRSA和其他耐药菌株的新抗生素和治疗策略。总之,美克西林(methicillin)在与细菌感染斗争中发挥了关键作用,但其有效性受到耐药性上升的挑战。与MRSA的持续斗争提醒我们负责任地使用抗生素的重要性,以及在传染病领域继续开展研究的必要性。随着我们向前发展,学习过去的经验并开发创新解决方案以应对细菌耐药性的不断演变是至关重要的。